Results 211 to 220 of about 85,155 (297)
ABSTRACT Irritability is a prevalent and impairing feature associated with autism, yet remains poorly understood, particularly in adults. Drawing heavily on insights translated from pediatric and transdiagnostic literatures, we propose that irritability in autistic individuals often reflects a psychophysiological stress or threat response, rooted in a ...
Hsiang‐Yuan Lin +3 more
wiley +1 more source
Timely or detailed? The impact of information disclosure on citizen co-production. [PDF]
Zhang C, Liu D, Peng B.
europepmc +1 more source
Aims Graduating medical students consistently report being unprepared for the complexity of prescribing in clinical practice. Current clinical prescribing teaching and authentic assessment are limited due to patient safety concerns. We aimed to examine the educational utility of supervised preprescribing as a learning process and potential authentic ...
Kellie A. Charles +7 more
wiley +1 more source
Diagnostic errors in clinical laboratory testing process: incidence and impacts on patient safety-a 3-year voluntary incident report analysis. [PDF]
Saengpattrachai M +7 more
europepmc +1 more source
Aims This study looks at the status of the same drugs conditionally approved by the Food and Drug Administration and Health Canada for the same oncology indication. Methods Lists of oncology drugs with a conditional approval from the Food and Drug Administration and Health Canada were generated and drug pairs with the same indication were matched ...
Joel Lexchin
wiley +1 more source
Cine Phase Contrast Magnetic Resonance Imaging of Calf Muscle Contraction in Pediatric Patients with Cerebral Palsy and Healthy Children: Comparison of Voluntary Motion and Electrically Evoked Motion. [PDF]
Weidensteiner C +9 more
europepmc +1 more source
Problem setting The emergence of therapeutic proteins has coincided with an increase of acute adverse immunostimulation (AIS). AIS has occured in clinical trials despite compliance with regulatory guidelines on preclinical evaluation and its incidence is anticipated to increase even further.
Juliette A. van den Noort +8 more
wiley +1 more source
Mapping the regulatory landscape for environmental sustainability of medical device practices within the European Union. [PDF]
Zarro M +4 more
europepmc +1 more source
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun +4 more
wiley +1 more source
Building a single market for data: Data spaces as pro-competitive infrastructure. [PDF]
Konstantopoulou ES.
europepmc +1 more source

